Protein C prevents the coagulopathic and lethal effects of Escherichia coli infusion in the baboon.
- 1 March 1987
- journal article
- research article
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 79 (3), 918-925
- https://doi.org/10.1172/jci112902
Abstract
Gram-negative septicemia elicits multiple abnormalities of the coagulation system. Although products of coagulation can lead to clot formation, thereby potentiating organ damage, recent work has shown that low concentrations of thrombin can protect animals from the shock state. Because these amounts of thrombin also lead to formation in vivo of the anticoagulant enzyme, activated protein C, we examined the role of protein C in modulation of Escherichia coli shock in baboons. First, we infused activated protein C and lethal concentrations of E. coli organisms, which prevented the coagulopathic, hepatotoxic, and lethal effects of E. coli. Second, using an antibody to protein C we blocked protein C activation in vivo to determine if this influenced the response to lethal and sublethal concentrations of E. coli organisms. Under these conditions the response to lethal concentrations of E. coli organisms was made more severe and the response to sublethal concentrations of E. coli was made lethal. The coagulopathic, hepatotoxic, and lethal responses in this latter case were prevented by infusion of exogenous protein C.This publication has 23 references indexed in Scilit:
- The Role of Fibrin Monomer and an in vivo Thrombin-Induced Anticoagulant in Experimental Venous ThrombosisScandinavian Journal of Haematology, 2009
- Activation of coagulation releases endothelial cell mitogens.The Journal of cell biology, 1986
- Relationship between protein C antigen and anticoagulant activity during oral anticoagulation and in selected disease states.Journal of Clinical Investigation, 1986
- Passive Immunization Against Cachectin/Tumor Necrosis Factor Protects Mice from Lethal Effect of EndotoxinScience, 1985
- DEFICIENCIES OF PROTEIN C, AN INHIBITOR OF BLOOD COAGULATIONThe Lancet, 1982
- Activation of Protein C In VivoJournal of Clinical Investigation, 1982
- Generation of fibrinolytic activity by infusion of activated protein C into dogs.Journal of Clinical Investigation, 1981
- Preparation and properties of bovine factor VIII (antihemophilic factor)Biochemistry, 1980
- Oxygen radicals mediate endothelial cell damage by complement-stimulated granulocytes. An in vitro model of immune vascular damage.Journal of Clinical Investigation, 1978
- Proteolytic activation of protein C from bovine plasmaBiochemistry, 1976